Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
6 Bekeken
• 07/30/23
0
0
insluiten
administrator
abonnees
Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties